Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid-Reference-Cited by-同舟云学术

Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid

Published:1998-11 Issue:4 Volume:42 Page:905-908
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Wilson WilliamR,Li AlanE,Cowan DavidS.M,Siim BronwynG

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference15 articles.

1. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon-38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids;Rewcastle;J Med Chem,1991

2. Comparative pharmacokinetics and plasma protein binding of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans and mice;Jameson;Proc Am Soc Clin Oncol,1997

3. Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid;Cliffe;Int J Radiat Oncol Biol Phys,1994

4. Enhancement of the antitumour effects of the antivascular agent 5,6-dimethylxanethenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs;Lash;Br J Cancer,1998

5. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents;Zwi;Oncol Res,1994

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions;Frontiers in Pharmacology;2024-04-10

2. Novel emerging nano-assisted anti-cancer strategies based on the STING pathway;Acta Materia Medica;2023

3. Targeting STING for cancer immunotherapy: From mechanisms to translation;International Immunopharmacology;2022-12

4. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy;Frontiers in Oncology;2022-08-29

5. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors;Cancers;2021-08-04